» Articles » PMID: 35630870

Mesoporous Silica Materials Loaded with Gallic Acid with Antimicrobial Potential

Abstract

This paper aimed to develop two types of support materials with a mesoporous structure of mobile crystalline matter (known in the literature as MCM, namely MCM-41 and MCM-48) and to load them with gallic acid. Soft templating methodology was chosen for the preparation of the mesoporous structures-the cylindrical micelles with certain structural characteristics being formed due to the hydrophilic and hydrophobic intermolecular forces which occur between the molecules of the surfactants (cetyltrimethylammonium bromide-CTAB) when a minimal micellar ionic concentration is reached. These mesoporous supports were loaded with gallic acid using three different types of MCM-gallic acid ratios (1:0.41; 1:0.82 and 1:1.21)-and their characterizations by FTIR, SEM, XRD, BET and drug release were performed. It is worth mentioning that the loading was carried out using a vacuum-assisted methodology: the mesoporous materials are firstly kept under vacuum at ~0.1 barr for 30 min followed by the addition of the polyphenol solutions. The concentration of the solutions was adapted such that the final volume covered the wet mesoporous support and-in this case-upon reaching normal atmospheric pressure, the solution was pushed inside the pores, and thus the polyphenols were mainly loaded inside the pores. Based on the S data, it can be seen that the specific surface area decreased considerably with the increasing ratio of gallic acid; the specific surface area decreased 3.07 and 4.25 times for MCM-41 and MCM-48, respectively. The sample with the highest polyphenol content was further evaluated from a biological point of view, alone or in association with amoxicillin administration. As expected, the MCM-41 and MCM-48 were not protective against infections-but, due to the loading of the gallic acid, a potentiated inhibition was recorded for the tested gram-negative bacterial strains. Moreover, it is important to mention that these systems can be efficient solutions for the recovery of the gut microbiota after exposure to antibiotics, for instance.

Citing Articles

Recent Advancements in Gallic Acid-Based Drug Delivery: Applications, Clinical Trials, and Future Directions.

Harwansh R, Deshmukh R, Shukla V, Khunt D, Prajapati B, Rashid S Pharmaceutics. 2024; 16(9).

PMID: 39339238 PMC: 11435332. DOI: 10.3390/pharmaceutics16091202.


Porous Silica Nanomaterials as Carriers of Biologically Active Natural Polyphenols: Effect of Structure and Surface Modification.

Trendafilova I, Popova M Pharmaceutics. 2024; 16(8).

PMID: 39204349 PMC: 11359489. DOI: 10.3390/pharmaceutics16081004.


The Antimicrobial Potency of Mesoporous Silica Nanoparticles Loaded with Extract.

Petrisor G, Motelica L, Trusca R, Mrt A, Vasilievici G, Tomescu J Pharmaceutics. 2024; 16(4).

PMID: 38675186 PMC: 11054826. DOI: 10.3390/pharmaceutics16040525.


Nanotechnology-based non-viral vectors for gene delivery in cardiovascular diseases.

Jiao L, Sun Z, Sun Z, Liu J, Deng G, Wang X Front Bioeng Biotechnol. 2024; 12:1349077.

PMID: 38303912 PMC: 10830866. DOI: 10.3389/fbioe.2024.1349077.


Very Large Pore Mesoporous Bioactive Silicate Glasses: Comparison of Behavior toward Classical Mesoporous Bioactive Glasses in Terms of Drug Loading/Release and Bioactivity.

Carrozza D, Ferrari E, Malavasi G Materials (Basel). 2024; 17(2).

PMID: 38255541 PMC: 10820009. DOI: 10.3390/ma17020373.


References
1.
Brentnall M, Rodriguez-Menocal L, De Guevara R, Cepero E, Boise L . Caspase-9, caspase-3 and caspase-7 have distinct roles during intrinsic apoptosis. BMC Cell Biol. 2013; 14:32. PMC: 3710246. DOI: 10.1186/1471-2121-14-32. View

2.
Ho H, Chang C, Ho W, Liao S, Lin W, Wang C . Gallic acid inhibits gastric cancer cells metastasis and invasive growth via increased expression of RhoB, downregulation of AKT/small GTPase signals and inhibition of NF-κB activity. Toxicol Appl Pharmacol. 2012; 266(1):76-85. DOI: 10.1016/j.taap.2012.10.019. View

3.
Yoshioka K, Kataoka T, Hayashi T, Hasegawa M, Ishi Y, Hibasami H . Induction of apoptosis by gallic acid in human stomach cancer KATO III and colon adenocarcinoma COLO 205 cell lines. Oncol Rep. 2000; 7(6):1221-3. DOI: 10.3892/or.7.6.1221. View

4.
Borges A, Ferreira C, Saavedra M, Simoes M . Antibacterial activity and mode of action of ferulic and gallic acids against pathogenic bacteria. Microb Drug Resist. 2013; 19(4):256-65. DOI: 10.1089/mdr.2012.0244. View

5.
Yuba E, Takashima M, Hayashi T, Kokuryo D, Aoki I, Harada A . Multifunctional Traceable Liposomes with Temperature-Triggered Drug Release and Neovasculature-Targeting Properties for Improved Cancer Chemotherapy. Mol Pharm. 2021; 18(9):3342-3351. DOI: 10.1021/acs.molpharmaceut.1c00263. View